Focus on five patients treated with cyclosporine up to 62 months

The Journal of Dermatological Treatment
Federico BardazziVera Tengattini

Abstract

Cyclosporine is a validated treatment for moderate to severe psoriasis. Long-term cyclosporine administration may induce toxic effects. The duration of treatment usually ranges from 10 to 16 weeks. However, some patients may take cyclosporine for a longer time. The objective of the present study is to evaluate the dose, efficacy and safety in long-term cyclosporine therapy. We studied the hospital records of patients with psoriasis treated with cyclosporine between 1 January 2009, and 30 April 2015. We decided to focus on patients who, for different reasons, have continued cyclosporine for more than 2 years. Five patients (2.69%) had been assuming cyclosporine for up to 62 months and had achieved a substantial response with no toxic effects. All of them were concerned about recurrence and all patients had personal reasons to prefer Cyclosporine over other drugs, including: familiar history of neurodegenerative disease, desire for motherhood, easy availability on prescription, systemic scleroderma, belenophobia. Cyclosporine is an acceptable monotherapy for psoriasis in selected patients. The prompt discontinuation of treatment usually results in resolution of any eventual toxicity.

References

Mar 1, 1993·Journal of the American Academy of Dermatology·G D Weinstein, G M White
Nov 1, 1996·Journal of the American Academy of Dermatology·N J LoweM T Grabie
May 15, 1998·The British Journal of Dermatology·A V PowlesL Fry
Apr 18, 2001·Dermatology : International Journal for Clinical and Investigative Dermatology·J M LachapelleS Jablonska
Apr 30, 2004·The British Journal of Dermatology·C E M GriffithsF Vanaclocha
Mar 19, 2005·Journal of Hypertension·Eoin O'BrienUNKNOWN European Society of Hypertension Working Group on Blood Pressure Monitoring
Oct 26, 2007·Journal of the European Academy of Dermatology and Venereology : JEADV·G Ch ChaidemenosF Tsatsou
Mar 6, 2008·Dermatology : International Journal for Clinical and Investigative Dermatology·M AugustinK Reich
Mar 17, 2011·Journal of the European Academy of Dermatology and Venereology : JEADV·A MazaC Paul
Dec 16, 2011·Journal of Molecular Cell Biology·Qizhi TangSang-Mo Kang
Mar 6, 2012·Journal of the European Academy of Dermatology and Venereology : JEADV·U Mrowietz
Apr 12, 2012·Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·Alexander NastUNKNOWN Berufsverband Deutscher Dermatologen (BVDD)
Nov 23, 2012·International Journal of Dermatology·Alessandro BorghiAnnarosa Virgili
Dec 28, 2012·Chemical Research in Toxicology·Frederic LamarcheEric Fontaine
Jan 3, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·V A AntonucciF Bardazzi
Feb 27, 2013·Journal of the European Academy of Dermatology and Venereology : JEADV·U MrowietzR B Warren
Jan 1, 2015·Archives of Dermatological Research·M A RadtkeMatthias Augustin

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

© 2021 Meta ULC. All rights reserved